000 01438 a2200361 4500
005 20250516201320.0
264 0 _c20150406
008 201504s 0 0 eng d
022 _a1521-4184
024 7 _a10.1002/ardp.201300242
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aModh, Rahul P
245 0 0 _aDesign, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
_h[electronic resource]
260 _bArchiv der Pharmazie
_cNov 2013
300 _a793-804 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylcholinesterase
_xmetabolism
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aCholinesterase Inhibitors
_xchemical synthesis
650 0 4 _aCoumarins
_xchemical synthesis
650 0 4 _aDrug Design
650 0 4 _aGPI-Linked Proteins
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aHydrophobic and Hydrophilic Interactions
650 0 4 _aMolecular Docking Simulation
650 0 4 _aPiperazines
_xchemical synthesis
650 0 4 _aQuantitative Structure-Activity Relationship
700 1 _aKumar, Sivakumar Prasanth
700 1 _aJasrai, Yogesh T
700 1 _aChikhalia, Kishor H
773 0 _tArchiv der Pharmazie
_gvol. 346
_gno. 11
_gp. 793-804
856 4 0 _uhttps://doi.org/10.1002/ardp.201300242
_zAvailable from publisher's website
999 _c23605784
_d23605784